Human HIV-1 gp160 protein (Recombinant) (STJP000346)
SPECIFICATIONS
ConjugationUnconjugated
ImmunogenRecombinant HIV gp160 encodes the immunodominant sequences of the HIV Transmembrane Glycoprotein 160. NA
General Information
| Short Description | Recombinant-Human HIV-1 gp160-protein was developed from. For use in research applications. |
| Note | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Formulation | 0.2 ยตm filtered 100mM PBS, pH4.5, 10mM tris HCL., 300mM Imidiasole, 8M Urea |
| Storage Instruction | Can be stored in working aliquots at 4ยฐC C for one month, or at-20ยฐC C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/ยตg (1EU/ยตg). NA |
Target Information
| Immunogen | Recombinant HIV gp160 encodes the immunodominant sequences of the HIV Transmembrane Glycoprotein 160. NA |
| Specificity | Immunoreative with sera of infected HIV individuals |
Additional Info
| Background | Recombinant HIV gp160 is fused to an Beta-galactosidase purification tag and migrates as 58kDa on PAGE. |
Information sourced from Uniprot.org